Kwality Pharmaceuticals LtdBSE: KPL

Kwality Pharmaceuticals Ltd Press Release Jan 01 2026

· Issued by Kwality Pharmaceuticals Ltd via BSE India

Filed with BSE · · 2 pages · English

Release

We wish to inform you that on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company, at its meeting held today i.e. on January 01, 2026 has, inter alia, considered and approved the appointment of Mr. PreetMohinder Singh Bedi (DIN: 11452004) as Additional Independent Director of the Company who shall hold office for a period of five (5) consecutive years with effect from 01st January, 2026 to 31st December, 2030(both days inclusive) subject to approval of the shareholders of the Company.

Kwality Pharmaceuticals Ltd on 6ix

In the deck

Earlier from Kwality Pharmaceuticals

Later from Kwality Pharmaceuticals

All Kwality Pharmaceuticals news releases